Laurus Labs Q1 Results
- BSE: 540222
- NSE: LAURUSLABS
- ISIN: INE947Q01028
- Sector: Biotechnology & Drugs
BSE
1,087.95
-9.95 (-0.91%)
-9.95 (-0.91%)Volume29.77 K
Updated: Mon 13 Apr, 2026 | 15:58:53
NSE
1,086.65-11.70 (-1.07%)
-11.70 (-1.07%)Volume1.23 M
Updated: Mon 13 Apr, 2026 | 15:25:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Laurus Labs Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,304.28 | 1,410.13 | -7.51% | 1,129.77 | 15.45% |
| Depreciation/ Amortization | 116.84 | 110.43 | 5.80% | 106.66 | 9.54% |
| Operating Income | 265.29 | 310.17 | -14.47% | 65.14 | 307.26% |
| Net Income | 163.02 | 233.67 | -30.23% | 12.42 | 1212.56% |
| Other Operating Expenses Total | 335.29 | 339.32 | -1.19% | 312.28 | 7.37% |
| Net Income Before Taxes | 224.22 | 312.34 | -28.21% | 18.46 | 1114.63% |
| Total Revenue | 1,569.57 | 1,720.30 | -8.76% | 1,194.91 | 31.35% |
| Selling/ General/ Admin Expenses Total | 214.80 | 177.70 | 20.88% | 173.98 | 23.46% |
| Diluted Normalized EPS | 3.02 | 4.33 | -30.27% | 0.23 | 1213.04% |